Indeed, a SOX2-targeting peptide, peptide 42 (sP42), significantly reduced esophageal squamous cell carcinoma (ESCC) KYSE450 and TE-1 proliferation, as well as migration and invasion [458]. This evidence concerns the gene SOX2 and esophageal squamous cell carcinoma.